Article Details
Retrieved on: 2025-10-09 20:13:23
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Fintel reports that on October 8, 2025, Aegis Capital reiterated coverage of AEON Biopharma (NYSEAM:AEON) with a Buy recommendation.
Article found on: www.nasdaq.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here